The add-on effect of dengzhan shengmai capsules on secondary prevention of ischemic stroke: A multicentre, randomised, placebo-controlled clinical trial.

CONCLUSIONS: The addition of DZSM capsules to standard secondary preventive agents provides additional benefits after the initial onset of ischemic stroke, reducing recurrent stroke without increasing severe adverse events. However, further study is needed to elucidate the role of DZSM on the updated practice of conventional secondary prevention for ischemic stroke.
PMID: 31519277 [PubMed - in process]

Source: Complementary Therapies in Medicine - September 16, 2019 Category: Complementary Medicine Authors: Cai Y, Zhang X, Huang Y, Wang L, Sun J, Liang W, Ou A, Yu B, Guo J, Zhao M, Ni X, Chen S Tags: Complement Ther Med Source Type: research